CLPT CLEARPOINT NEURO INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 5 analyst firms say about CLEARPOINT NEURO INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
4 rated views · 5 analyst/firm records · 5 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 2 reports on CLPT from 2 analyst firms in the last 90 days (5 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it.
No firm's latest available rating differs from its previous one.
Latest observed target change: Stifel lowered its target from $22.00 (set 4 Aug 2026) to $18.00 on 29 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Neil Chatterji | Buy | 18 Jun 2026 | 30.00 USD |
| Lake Street Capital Markets | Frank Takkinen | Buy | 2 Jun 2026 | 25.00 USD |
| Stifel | Tom Stephan | Buy | 29 Oct 2026 | 18.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.